SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-051827
Filing Date
2019-09-27
Accepted
2019-09-27 16:58:33
Documents
1
Period of Report
2019-09-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a19-19121_38k.htm 8-K 35257
  Complete submission text file 0001104659-19-051827.txt   36919
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17082 | Film No.: 191122746
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences